EG vs NKTR · P/E 17, rev $8.03B vs rev $21.0M
Everest Group Ltd (EG) versus Nektar Therapeutics (NKTR) — a side-by-side from cached financials, not a winner call.
Everest Group Ltd (EG) is a insurance - reinsurance company listed on US.
Nektar Therapeutics (NKTR) is a biotechnology company listed on US.
Latest reported EG revenue for 2026-06-30 was $8.03B. Net income was $1.21B. Revenue was up 97.4% from 2026-03-31 to 2026-06-30. EG currently screens at market cap $14.52B and trailing P/E 17.2.
Latest reported NKTR revenue for 2026-06-30 was $21.0M. Net income was -$85.5M. Revenue was up 93.3% from 2026-03-31 to 2026-06-30. NKTR currently screens at market cap $307.2M.
EG currently screens at market cap $14.52B and trailing P/E 17.2. NKTR currently screens at market cap $307.2M.
Not investment advice. Open the EG and NKTR stock pages for the full models.
Not investment advice.